Abacus Global Management Inc., also known as ABL, is a renowned life settlements provider, committed to aiding clients appraise and vend their life insurance plan to optimize their financial returns and opportunities. The company is committed to providing best-in-class services and focusing on the importance of the individual in any transaction.
Established in 2004 and headquartered in Orlando, Florida, ABL has managed to revolutionize the life settlement industry over its decade-long tenure. The core principle of ABL's business model rests on providing individuals with an alternative solution for their burdensome life insurance policies, a rather unorthodox yet lucrative avenue in the financial industry during its inception.
Operating on the vanguard of life settlement providers, ABL underpins the increasing need among policyholders to unlock the full potential of their life insurance policy. Policyholders are encouraged to sell their policy to an investor, with Abacus Global Management Inc. functioning as the competent intermediary that evaluates the policy, negotiates the terms, and ensures both ends receive fair treatment.
Abacus Global Management Inc. values transparency, trust, and privacy as its cornerstones, ensuring policyholders, their beneficiaries, and investors are provided full disclosure throughout the process, treated with utmost respect, and data privacy norms strictly adhered. This becomes particularly paramount when dealing with sensitive aspects like life insurance that entails health records and other personal data.
To ascertain an optimal return on life insurance policies, Abacus performs a comprehensive policy analysis based on a multitude of factors, including the type of insurance, premiums, policy value, and mortality projections. This enables the arbitration of a fair market value, beneficial to both selling policyholders and potential investors.
Abacus Global Management Inc. also champions longevity hedging, offering an innovative platform to institutional investors seeking to mitigate the risk of longevity. By providing investors with unique, uncorrelated asset classes, Abacus aims to diminish the exposure to longevity risk.
Adding another feather to its cap, ABL is recognized and accredited by the Better Business Bureau with an A+ rating, testifying to their credibility and excellence in serving customers.
In summary, Abacus Global Management Inc. Inc has proven over the years to be an industry leader in the life settlements realm, offering essential solutions to both individual policyholders and institutional investors. Driven by transparency, trust, and privacy, with a customer-centric approach, ABL continues to redefine the life insurance landscape, demonstrating its commitment to improving the financial well-being and lives of its clients.
Income statement
Balance sheet statement
Cash flow statement
Current assets / Current liabilities
Equity / Debt / Cash
Dividends
Abacus Global Management (ABX) reported higher Q2 2026 revenues of US$73.02 million, but net income and diluted EPS declined to US$6.63 million and US$0.07 respectively, indicating margin pressure. This shift from top-line growth to concerns over profitability and rising costs has impacted the investment narrative, leading to a reassessment by the market despite ongoing buybacks and strategic alliances. Investors are now more focused on cost discipline and execution risk, particularly given the new management team.
Abacus Global Management, Inc. announced its decision to transfer its common stock and senior notes listings from the Nasdaq Capital Market to the New York Stock Exchange (NYSE). Trading on the NYSE is expected to begin on December 30, 2025, under new symbols. This move follows impressive financial results for Abacus Life Inc., a related entity, and highlights significant strategic activities for the company.
Squarepoint Ops LLC significantly increased its stake in Abacus Life, Inc. (NASDAQ:ABL) by 1,264.1% in Q2, acquiring an additional 201,490 shares. This move brings their total holdings to 217,430 shares, valued at approximately $1.12 million, representing about 0.22% of the company. Abacus Life has received mixed analyst ratings, with a consensus of "Moderate Buy" and an average price target of $12.67, while experiencing a recent 2.9% dip in stock price.
Grandeur Peak Global Advisors LLC significantly increased its stake in Abacus Life, Inc. (NASDAQ:ABL) by 102.2% in the second quarter, bringing its total to 390,645 shares valued at approximately $2.01 million. This move is part of a broader trend of rising institutional interest, with other firms like Charles Schwab and CSM Advisors also increasing or initiating positions. Despite mixed analyst ratings, Abacus Life has a consensus "Moderate Buy" rating with a target price of $12.67, and recently surpassed quarterly EPS and revenue estimates while announcing an annual dividend.
Abacus (NASDAQ: ABL) announced the sale of $50 million in securitized life insurance assets to institutional investors. The transaction, structured as an above investment-grade rated collateralized note with a mid-single-digit yield, closed on October 22, 2025. This initiative aims to provide institutional investors, banks, and insurance companies with direct, rated exposure to life insurance assets, offering diversification and reduced correlation to traditional markets.